The Pathophysiology of Irritable Bowel SyndromeCME - Medscape

More documents

Recommendations

Info

The Pathophysiology of Irritable Bowel Syndrome CMEFaculty and DisclosuresAs an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of aneducation activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines “relevantfinancial relationships” as financial relationships in any amount, occurring within the past 12 months, including financialrelationships of a spouse or life partner, that could create a conflict of interest.Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Foodand Drug Administration, at first mention and where appropriate in the content.AuthorMichael Camilleri, MDProfessor of Medicine, Pharmacology, and Physiology, Mayo Clinic, Rochester, MinnesotaDisclosure: Michael Camilleri, MD, has disclosed the following relevant financial relationships:Served as a speaker or a member of a speakers bureau for: ShireReceived grants for clinical research from: Salix Pharmaceuticals, Sk Life Science, and Tsumura & Co.Dr Camilleri does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDAfor use in the United States.Dr Camilleri does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by theFDA for use in the United States.EditorsJulia MuinoScientific Director, Medscape, LLCDisclosure: Julia Muino has disclosed no relevant financial relationships.Kristen L. DascoliClinical Editor, Medscape, LLCDisclosure: Kristen L. Dascoli has disclosed no relevant financial relationships.CME ReviewerNafeez Zawahir, MDCME Clinical Director, Medscape, LLCDisclosure: Nafeez Zawahir, MD, has disclosed no relevant financial relationships.Pg.4
www.medscape.org/lecture/ibs/pathophysiologySlide 1.Dr Michael Camilleri: Hello. I am Michael Camilleri, professor of medicine, pharmacology, and physiology at the Mayo Clinic inRochester, Minnesota. I would like to welcome you to this program titled “Pathophysiology of Irritable Bowel Syndrome.”Slide 2.Irritable bowel syndrome (IBS) affects 10% to 20% of the population in developed countries. [1] The diagnosis of IBS is traditionallybased on the presence of symptoms of recurrent abdominal pain or discomfort at least 3 days per month in the previous 3 monthsin association with 2 or more of the following: an improvement with defecation, an onset that is associated with a change in thefrequency of bowel movements, or an onset associated with a change in the form or appearance of stool. [2]Pg.5
Page 3: www.medscape.org/lecture/ibs/pathop
Page 7 and 8: www.medscape.org/lecture/ibs/pathop
Page 19: www.medscape.org/lecture/ibs/pathop

The Pathophysiology of Irritable Bowel SyndromeCME - Medscape

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?